Atlas Brown’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $557K | Buy |
5,386
+33
| +0.6% | +$2.95K | 0.15% | 138 |
|
|
2026
Q1 | $384K | Buy |
5,353
+276
| +5% | +$21.3K | 0.12% | 158 |
|
|
2025
Q4 | $403K | Buy |
5,077
+34
| +0.7% | +$2.68K | 0.12% | 154 |
|
|
2025
Q3 | $380K | Sell |
5,043
-220
| -4% | -$15.1K | 0.11% | 158 |
|
|
2025
Q2 | $363K | Buy |
5,263
+370
| +8% | +$24.3K | 0.12% | 163 |
|
|
2025
Q1 | $331K | Buy |
4,893
+142
| +3% | +$8.5K | 0.12% | 164 |
|
|
2024
Q4 | $213K | Sell |
4,751
-492
| -9% | -$27.6K | 0.07% | 200 |
|
|
2024
Q3 | $330K | Sell |
5,243
-1,977
| -27% | -$115K | 0.11% | 156 |
|
|
2024
Q2 | $426K | Buy |
7,220
+51
| +0.7% | +$3.19K | 0.15% | 132 |
|
|
2024
Q1 | $572K | Sell |
7,169
-782
| -10% | -$59.7K | 0.21% | 105 |
|
|
2023
Q4 | $628K | Sell |
7,951
-54
| -0.7% | -$3.84K | 0.26% | 102 |
|
|
2023
Q3 | $559K | Buy |
8,005
+21
| +0.3% | +$1.49K | 0.25% | 99 |
|
|
2023
Q2 | $552K | Sell |
7,984
-240
| -3% | -$17.1K | 0.24% | 106 |
|
|
2023
Q1 | $611K | Sell |
8,224
-982
| -11% | -$82.3K | 0.28% | 102 |
|
|
2022
Q4 | $858K | Sell |
9,206
-712
| -7% | -$68.7K | 0.42% | 75 |
|
|
2022
Q3 | $946K | Buy |
9,918
+85
| +0.9% | +$8.41K | 0.48% | 68 |
|
|
2022
Q2 | $911K | Buy |
9,833
+167
| +2% | +$16.3K | 0.43% | 73 |
|
|
2022
Q1 | $978K | Sell |
9,666
-165
| -2% | -$17.3K | 0.4% | 76 |
|
|
2021
Q4 | $1.01M | Sell |
9,831
-42
| -0.4% | -$3.88K | 0.39% | 79 |
|
|
2021
Q3 | $838K | Buy |
9,873
+837
| +9% | +$70.1K | 0.36% | 84 |
|
|
2021
Q2 | $754K | Buy |
9,036
+113
| +1% | +$9.25K | 0.33% | 94 |
|
|
2021
Q1 | $671K | Buy |
8,923
+1,814
| +26% | +$132K | 0.32% | 96 |
|
|
2020
Q4 | $486K | Buy |
7,109
+1,017
| +17% | +$66.1K | 0.25% | 109 |
|
|
2020
Q3 | $356K | Buy |
6,092
+1
| +0% | +$62 | 0.21% | 114 |
|
|
2020
Q2 | $396K | Sell |
6,091
-328
| -5% | -$20.7K | 0.25% | 107 |
|
|
2020
Q1 | $381K | Buy |
6,419
+773
| +14% | +$51.6K | 0.3% | 95 |
|
|
2019
Q4 | $419K | Buy |
5,646
+259
| +5% | +$18.2K | 0.26% | 101 |
|
|
2019
Q3 | $340K | Buy |
5,387
+272
| +5% | +$16.1K | 0.24% | 108 |
|
|
2019
Q2 | $279K | Buy |
5,115
+383
| +8% | +$20.6K | 0.19% | 122 |
|
|
2019
Q1 | $255K | Buy |
+4,732
| New | +$292K | 0.18% | 127 |
|
|
2015
Q1 | – | Sell |
-2,546
| Closed | -$245K | – | 112 |
|
|
2014
Q4 | $245K | Hold |
2,546
| – | – | 0.07% | 94 |
|
|
2014
Q3 | $203K | Sell |
2,546
-250
| -9% | -$19.7K | 0.08% | 100 |
|
|
2014
Q2 | $211K | Hold |
2,796
| – | – | 0.1% | 95 |
|
|
2014
Q1 | $209K | Sell |
2,796
-354
| -11% | -$25K | 0.11% | 84 |
|
|
2013
Q4 | $225K | Buy |
+3,150
| New | +$202K | 0.16% | 69 |
|
Other funds holding CVS
Atlas Brown's CVS Position: Q2 2026 in Review
Atlas Brown increased its CVS Health (CVS) stake by 0.62% in Q2 2026, buying an estimated $2.95K and bringing the position to 5,386 shares worth $557K. The position accounts for 0.15% of the portfolio, ranked #138.
Atlas Brown first reported a position in CVS in Q4 2013 and has held it in 35 quarters since. The position peaked at $1.01M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Atlas Brown held 5,386 shares of CVS Health worth $557K as of Q2 2026.
- Atlas Brown bought 33 CVS Health shares in Q2 2026, an estimated $2.95K.
- CVS Health made up 0.15% of Atlas Brown's portfolio in Q2 2026, its #138 holding.
- Atlas Brown first reported a position in CVS Health in Q4 2013 and has held it in 35 quarters since.
- Atlas Brown's CVS Health position peaked at $1.01M in Q4 2021.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Atlas Brown's 13F filing for Q2 2026, filed 9 Jul 2026.